ABOUT US

We are a forward-thinking, mid-size early phase contract research organization, in Canada and the U.S., offering biopharmaceutical companies of all sizes a proven, flexible approach to early drug development, including preclinical safety testing, clinical pharmacology (Phase I to Phase II), bioanalysis (preclinical to Phase IV), research services, and manufacturing and analytical services. Focused on your success … always available and always looking ahead. Moving in unison to deliver big impact with a personal touch.

More About Us

...working with Altasciences has been excellent, from both a bioanalytical, and a bioavailability study perspective. We are really impressed with their planning and execution abilities – I would not consider another provider for future work.

James M Mackay, President and Chief Executive Officer, Aristea Therapeutics

RESOURCE CENTER

Video - Altasciences - Bioanalysis Services

Watch the Video

Altasciences - Bioanalysis Services

Focused on your needs, our specialists provide appropriate support for precision bioanalysis, and a full range of research services for a wide range of study types — working with you to accelerate development, meet your milestones, and ensure compliant, on-time regulatory submissions for your drug candidates.

View All News & Events Go to Resource Center

SELECT A CATEGORY BELOW:

Careers

Join our team! Work at Altasciences - View all clinical job postings

Bring your talents and forward-thinking approach to Altasciences and help us develop medicines for those who need them, faster. We have a number of opportunities for you to explore.

Learn More

NEWS & EVENTS

Altasciences Completes Phase I Study on Gimsilumab for ARDS in COVID-19

Related Press Release

Altasciences Completes Phase I Study on Gimsilumab for ARDS in COVID-19

Mar 27, 2020

Altasciences has completed a Phase I study for the development of gimsilumab, a fully human monoclonal antibody that targets granulocyte-macrophage colony stimulating factor (GM-CSF), found to be up-regulated in SARS CoV-2 in patients with or at risk of developing acute respiratory distress syndrome (ARDS).

View All News & Events Go to Resource Center

SELECT A CATEGORY BELOW:

Our Solutions

May 2019

»ACCESS FULL NEWSLETTER

The Value of Integrated Anatomic and Clinical Pathology Assessments in Toxicology Studies

Five Principles to Follow for a Successful Regulatory Inspection

Scientific Journal

Read an insightful case study on the challenges encountered in Anti-Drug Antibody (ADA) assays in our latest issue of The Altascientist.

Bioanalytical Corner

Take a look at our latest assay list, scientific posters, and register for an upcoming webinar.

Industry News

Learn more about how and why Altasciences was recently recognized by the industry.

Press Room

Details on the expansion of our purpose-built testing facility and all our latest news!

Blog

A lighter look at what we do, how we do it, and the human health impacts. In our latest blogs, we discuss genetic therapies and blood collection in preclinical safety assessment.

THERAPEUTIC AREAS

Our deep expertise and capabilities in a broad range of therapeutic areas encompasses preclinical and early clinical studies for both small molecules and biologics. We can manage your entire program, as well as provide comprehensive support research services and bioanalytical expertise.

Please see Therapeutic Areas for a fuller discussion of our capabilities and expertise.

Learn More

This site uses cookies to store information on your computer and improve your browsing experience. By remaining on this site, you consent to the placement of these cookies. Read our Cookie Policy to learn more.

Working as a flexible, attentive extension of your team, we offer all you need to move your molecule forward.

Send Us A Message

STAY CONNECTED

2019 © Altasciences. All Rights Reserved.

Cookie Policy | Privacy Policy